{"j.efsa.2016.4491.pdf": "tableofcontentsabstract.................................................................................................................................................1summary...............................................................................................................................................3background...........................................................................................................................................6theactivesubstanceandtheformulatedproduct.....................................................................................7conclusionsoftheevaluation..................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis..............................................72.mammaliantoxicity...........................................................................................................................83.residues..........................................................................................................................................94.environmentalfateandbehaviour.....................................................................................................105.ecotoxicology...................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments...............................................................................137.datagaps........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.......................169.concerns.........................................................................................................................................169.1.issuesthatcouldnotbenalised......................................................................................................169.2.criticalareasofconcern....................................................................................................................179.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..........................................17references.............................................................................................................................................18abbreviations.........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation........................22appendixbusedcompoundcodes.......................................................................................................2", "j.efsa.2016.4492.pdf": "tableofcontentsabstract.............................................................................................................................................1summary...........................................................................................................................................3background.......................................................................................................................................6theactivesubstanceandtheformulatedproduct.................................................................................7conclusionsoftheevaluation..............................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis........................................72.mammaliantoxicity.....................................................................................................................83.residues....................................................................................................................................94.environmentalfateandbehaviour...............................................................................................115.ecotoxicology.............................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments.........................................................................147.datagaps..................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.................169.concerns...................................................................................................................................169.1.issuesthatcouldnotbenalised................................................................................................169.2.criticalareasofconcern..............................................................................................................179.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered....................................17references.........................................................................................................................................18abbreviations.....................................................................................................................................19appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation....................21appendixbusedcompoundcodes...................................................................................................22", "j.efsa.2016.4493.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................85.ecotoxicology....................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments............................................................................................107.datagaps.........................................................................................................................................108.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................119.concerns..........................................................................................................................................119.1.issuesthatcouldnotbenalised.......................................................................................................119.2.criticalareasofconcern.....................................................................................................................119.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................12references...............................................................................................................................................12abbreviations...........................................................................................................................................13appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2016.4494.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis..................................................................................................................................62.mammaliantoxicity............................................................................................................................7generaldata............................................................................................................................................7toxicitystudies........................................................................................................................................7secondarymetabolites/toxins....................................................................................................................7referencevaluesandexposure.................................................................................................................83.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions..................................................................................................95.ecotoxicology....................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments......................................................................107.datagaps.........................................................................................................................................118.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................13abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2016.4498.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments................................................................................157.datagaps.........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references...............................................................................................................................................19abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2016.4500.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments..............................................................157.datagaps.........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2016.4503.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments................................................................................147.datagaps.........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................179.concerns..........................................................................................................................................179.1.issuesthatcouldnotbenalised.......................................................................................................179.2.criticalareasofconcern.....................................................................................................................179.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................18references..............................................................................................................................................18abbreviations..........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................22appendixbusedcompoundcodes........................................................................................................23", "j.efsa.2016.4504.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................5theactivesubstanceandtheformulatedproduct......................................................................................6conclusionsoftheevaluation...................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................83.1representativeuseresidues...............................................................................................................83.2maximumresiduelevels.....................................................................................................................94.environmentalfateandbehaviour......................................................................................................95.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments............................................................................117.datagaps.........................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................139.1.issuesthatcouldnotbenalised.......................................................................................................139.2.criticalareasofconcern.....................................................................................................................149.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................14references..............................................................................................................................................15abbreviations..........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................17appendixbusedcompoundcodes........................................................................................................18", "j.efsa.2016.4515.pdf": "tableofcontentsabstract.................................................................................................................................................1summary...............................................................................................................................................3background...........................................................................................................................................6theactivesubstanceandtheformulatedproduct.....................................................................................7conclusionsoftheevaluation..................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis..........................................72.mammaliantoxicity.......................................................................................................................83.residues......................................................................................................................................103.1.representativeuseresidues..........................................................................................................103.2.maximumresiduelevels................................................................................................................114.environmentalfateandbehaviour.................................................................................................115.ecotoxicology...............................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments.....................................................157.datagaps....................................................................................................................................177.1.datagapsidentiedfortherepresentativeusesevaluated..............................................................177.2.datagapsidentiedforthemaximumresiduelevelapplications......................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied...................188.1.particularconditionsproposedfortherepresentativeusesevaluated................................................188.2.particularconditionsproposedforthemaximumresiduelevelapplications.......................................189.concerns.....................................................................................................................................199.1.concernsfortherepresentativeusesevaluated..............................................................................199.1.1.issuesthatcouldnotbenalised..................................................................................................199.1.2.criticalareasofconcern................................................................................................................199.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered......................................209.2.issuesrelatedtothemaximumresiduelevelapplications................................................................219.2.1.issuesnotnalisedunderthemaximumresiduelevelapplications...................................................219.2.2.consumerriskidentiedunderthemaximumresiduelevelapplications............................................21references.............................................................................................................................................21abbreviations.........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation........................24appendixbusedcompoundcodes.......................................................................................................2", "j.efsa.2016.4517.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................5theactivesubstanceandtheformulatedproduct......................................................................................6conclusionsoftheevaluation...................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis..............................................62.mammaliantoxicity...........................................................................................................................72.1.generaldata....................................................................................................................................72.2.toxicitystudies.................................................................................................................................72.3.secondarymetabolites/toxins............................................................................................................72.4.referencevaluesandexposure.........................................................................................................83.residues..........................................................................................................................................84.environmentalfateandbehaviour.....................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism..............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions............................................................................................95.ecotoxicology...................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments...............................................................................107.datagaps........................................................................................................................................118.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.......................129.concerns.........................................................................................................................................129.1.issuesthatcouldnotbenalised......................................................................................................129.2.criticalareasofconcern....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..........................................12references..............................................................................................................................................13abbreviations..........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................15appendixbusedcompoundcodes........................................................................................................16", "j.efsa.2016.4518.pdf": "tableofcontentsabstract...............................................................................................................................................1summary.............................................................................................................................................3background.........................................................................................................................................5theactivesubstanceandtheformulatedproduct...................................................................................6conclusionsoftheevaluation................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................62.mammaliantoxicity.........................................................................................................................73.residues........................................................................................................................................84.environmentalfateandbehaviour...................................................................................................95.ecotoxicology.................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments.............................................................................127.datagaps......................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................149.concerns.......................................................................................................................................159.1.issuesthatcouldnotbenalised....................................................................................................159.2.criticalareasofconcern..................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................16references...........................................................................................................................................16abbreviations.......................................................................................................................................17appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation......................19appendixbusedcompoundcode(s)...................................................................................................20", "j.efsa.2016.4554.pdf": "tableofcontentsabstract....................................................................................................................................................1summary..................................................................................................................................................3background..............................................................................................................................................6theactivesubstanceandtheformulatedproduct........................................................................................7conclusionsoftheevaluation.....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis................................................72.mammaliantoxicity.............................................................................................................................83.residues............................................................................................................................................94.environmentalfateandbehaviour.......................................................................................................115.ecotoxicology.....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments.................................................................................157.datagaps..........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.........................189.concerns...........................................................................................................................................189.1.issuesthatcouldnotbenalised........................................................................................................189.2.criticalareasofconcern......................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered............................................19references................................................................................................................................................20abbreviations............................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation...........................23appendixbusedcompoundcodes..........................................................................................................24", "j.efsa.2016.4569.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments............................................................................................177.datagapsidentiedfortherepresentativeusesevaluated...................................................................198.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................219.concernsfortherepresentativeusesevaluated...................................................................................219.1.issuesthatcouldnotbenalised.......................................................................................................219.2.criticalareasofconcern.....................................................................................................................219.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................22references...............................................................................................................................................23abbreviations...........................................................................................................................................24appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................26appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2016.4574.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................137.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................159.concerns..........................................................................................................................................159.1.issuesthatcouldnotbenalised.......................................................................................................159.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................16references...............................................................................................................................................16abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................20appendixbusedcompoundcodes.........................................................................................................21", "j.efsa.2016.4575.pdf": "tableofcontentsabstract....................................................................................................................................................1summary..................................................................................................................................................3background..............................................................................................................................................5theactivesubstanceandtheformulatedproduct........................................................................................6conclusionsoftheevaluation.....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.................................................62.mammaliantoxicity..............................................................................................................................73.residues.............................................................................................................................................94.environmentalfateandbehaviour........................................................................................................105.ecotoxicology......................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments.............................................................................................137.datagaps...........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied..........................169.concerns............................................................................................................................................179.1.issuesthatcouldnotbenalised.........................................................................................................179.2.criticalareasofconcern.......................................................................................................................179.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.............................................18references................................................................................................................................................18abbreviations............................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation...........................22appendixbusedcompoundcodes..........................................................................................................23", "j.efsa.2016.4584.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)........................................................................157.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)............................20references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcode(s).......................................................................................................2", "j.efsa.2016.4605.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................157.datagaps.........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references..............................................................................................................................................20abbreviations..........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................24appendixbusedcompoundcodes........................................................................................................25", "j.efsa.2016.4609.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................187.datagaps.........................................................................................................................................218.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................239.concerns..........................................................................................................................................239.1.issuesthatcouldnotbenalised.......................................................................................................239.2.criticalareasofconcern.....................................................................................................................249.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................25references..............................................................................................................................................25abbreviations..........................................................................................................................................27appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................29appendixbusedcompoundcodes........................................................................................................30", "j.efsa.2016.4610.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables1-4).......................................................................167.datagaps.........................................................................................................................................198.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................209.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................21abbreviations...........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................25appendixbusedcompoundcodes.........................................................................................................26", "j.efsa.2016.4612.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................62.mammaliantoxicity.........................................................................................................................73.residues........................................................................................................................................94.environmentalfateandbehaviour...................................................................................................105.ecotoxicology.................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables1-4)........................................................147.datagaps......................................................................................................................................177.1.datagapsidentiedfortherepresentativeusesevaluated................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................188.1.particularconditionsproposedfortherepresentativeusesevaluated..................................................189.concerns.......................................................................................................................................189.1.concernsfortherepresentativeusesevaluated................................................................................189.1.1.issuesthatcouldnotbenalised....................................................................................................189.1.2.criticalareasofconcern..................................................................................................................199.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2017.4650.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions......................................................................................................95.ecotoxicology....................................................................................................................................95.1.infectivenessandpathogenicityofmildpepinomosaicvirusisolatevx1................................................95.2.riskfromimpuritynicotine.................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................13abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2017.4651.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.............................................................................................85.ecotoxicology....................................................................................................................................95.1.infectivenessandpathogenicityofmildpepinomosaicvirusisolatevc1................................................95.2.riskfromimpuritynicotine.................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................13abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2016.4657.pdf": "tableofcontentsabstract.................................................................................................................................................1summary...............................................................................................................................................3background...........................................................................................................................................5theactivesubstanceandtheformulatedproduct.....................................................................................6conclusionsoftheevaluation..................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis..........................................62.mammaliantoxicity.......................................................................................................................73.residues......................................................................................................................................84.environmentalfateandbehaviour.................................................................................................85.ecotoxicology...............................................................................................................................86.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)....................................................107.datagaps....................................................................................................................................118.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied...................119.concerns.....................................................................................................................................119.1.concernsfortherepresentativeusesevaluated..............................................................................119.1.1.issuesthatcouldnotbenalised..................................................................................................119.1.2.criticalareasofconcern................................................................................................................119.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered......................................12references.............................................................................................................................................12abbreviations.........................................................................................................................................13appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation........................14", "j.efsa.2017.4668.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theidentityofthemicroorganismandthepropertiesoftheformulatedproduct..........................................8conclusionsoftheevaluation...................................................................................................................81.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis...........................................................................................................................................82.mammaliantoxicity...........................................................................................................................93.residues..........................................................................................................................................104.environmentalfateandbehaviour.....................................................................................................104.1.fateandbehaviourintheenvironmentofthemicroorganism..............................................................114.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions......................................................................................................115.ecotoxicology...................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)............................................................147.datagaps........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.......................169.concerns.........................................................................................................................................169.1.issuesthatcouldnotbenalised......................................................................................................169.2.criticalareasofconcern....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)............................17references..............................................................................................................................................17abbreviations..........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................20appendixbusedcompoundcodes........................................................................................................21", "j.efsa.2017.4693.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................8conclusionsoftheevaluation...................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis..............................................82.mammaliantoxicity...........................................................................................................................93.residues..........................................................................................................................................114.environmentalfateandbehaviour.....................................................................................................125.ecotoxicology...................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments...............................................................................167.datagaps........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.......................209.concerns.........................................................................................................................................219.1.issuesthatcouldnotbenalised......................................................................................................219.2.criticalareasofconcern....................................................................................................................219.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..........................................21references..............................................................................................................................................22abbreviations..........................................................................................................................................24appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................25appendixbusedcompoundcodes........................................................................................................26", "j.efsa.2017.4695.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................62.mammaliantoxicity.........................................................................................................................73.residues........................................................................................................................................94.environmentalfateandbehaviour...................................................................................................105.ecotoxicology.................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).......................................................137.datagaps......................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................169.concerns.......................................................................................................................................169.1.concernsfortherepresentativeusesevaluated................................................................................169.1.1.issuesthatcouldnotbenalised....................................................................................................169.1.2.criticalareasofconcern..................................................................................................................169.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................17references...............................................................................................................................................18abbreviations...........................................................................................................................................19appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................21appendixbusedcompoundcodes.........................................................................................................22", "j.efsa.2017.4700.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................8conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................145.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................187.datagaps.........................................................................................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................229.concerns..........................................................................................................................................229.1.issuesthatcouldnotbenalised.......................................................................................................229.2.criticalareasofconcern.....................................................................................................................229.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................23references...............................................................................................................................................24abbreviations...........................................................................................................................................26appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................28appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2017.4722.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................72.mammaliantoxicity.........................................................................................................................83.residues........................................................................................................................................94.environmentalfateandbehaviour...................................................................................................115.ecotoxicology.................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)........................................................147.datagaps......................................................................................................................................167.1.datagapsidentiedfortherepresentativeusesevaluated................................................................167.2.datagapsidentiedforthemaximumresiduelevelapplications........................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................189.concerns.......................................................................................................................................189.1.issuesthatcouldnotbenalised....................................................................................................189.2.criticalareasofconcern..................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................199.4.issuesrelatedtothemaximumresiduelevelapplications..................................................................199.4.1.issuesnotnalisedunderthemaximumresiduelevelapplications.....................................................199.4.2.consumerriskidentiedunderthemaximumresiduelevelapplications..............................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation...........................23appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2017.4790.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................105.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................157.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................179.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)............................19references...............................................................................................................................................19abbreviations...........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................22appendixbusedcompoundcodes.........................................................................................................23", "j.efsa.2017.4831.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis.....................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviourofthemicroorganism......................................................................85.ecotoxicology....................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)......................................................107.datagaps.........................................................................................................................................118.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................12references...............................................................................................................................................13abbreviations...........................................................................................................................................13appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2017.4832.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................157.datagaps.........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................179.concerns..........................................................................................................................................179.1.issuesthatcouldnotbenalised.......................................................................................................179.2.criticalareasofconcern.....................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................18references...............................................................................................................................................19abbreviations...........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................22appendixbusedcompoundcodes.........................................................................................................23", "j.efsa.2017.4836.pdf": "tableofcontentsabstract.....................................................................................................................................................1summary...................................................................................................................................................3background...............................................................................................................................................5theactivesubstanceandtheformulatedproduct.........................................................................................6conclusionsoftheevaluation......................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.................................................62.mammaliantoxicity..............................................................................................................................73.residues.............................................................................................................................................74.environmentalfateandbehaviour........................................................................................................85.ecotoxicology......................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)..........................................................................107.datagaps...........................................................................................................................................117.1.datagapsidentiedfortherepresentativeusesevaluated.....................................................................118.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied..........................119.concerns............................................................................................................................................119.1.issuesthatcouldnotbenalised.........................................................................................................119.2.criticalareasofconcern.......................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.............................................12references.................................................................................................................................................13abbreviations.............................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation............................16", "j.efsa.2017.4852.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................147.datagaps.........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................159.concerns..........................................................................................................................................169.1.issuesthatcouldnotbenalised.......................................................................................................169.2.criticalareasofconcern.....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................17references...............................................................................................................................................17abbreviations...........................................................................................................................................19appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................21appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2017.4868.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................7mammaliantoxicity..................................................................................................................................7residues(consumerriskassessment).......................................................................................................8environmentalfateandbehaviour............................................................................................................8overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables24)..............................................................................12datagaps...............................................................................................................................................15concerns................................................................................................................................................151.issuesthatcouldnotbenalised..........................................................................................................152.criticalareasofconcern........................................................................................................................153.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..............................................16references..............................................................................................................................................16abbreviations..........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation(relevantforthecurrentassessment)................................................................................................................................18appendixbusedcompoundcodes........................................................................................................19", "j.efsa.2017.4874.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................95.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(table15)..........................................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................139.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................14abbreviations...........................................................................................................................................15appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................17appendixbusedcompoundcodes.........................................................................................................18", "j.efsa.2017.4905.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis..........................................................................................................................................72.mammaliantoxicity............................................................................................................................82.1.generaldata.....................................................................................................................................82.2.toxicitystudies..................................................................................................................................82.3.secondarymetabolites/toxins.............................................................................................................82.4.referencevaluesandexposure..........................................................................................................93.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................137.datagaps.........................................................................................................................................157.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................169.concerns..........................................................................................................................................169.1.issuesthatcouldnotbenalised.......................................................................................................169.2.criticalareasofconcern.....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................17references...............................................................................................................................................17abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................19appendixbusedcompoundcodes.........................................................................................................20", "j.efsa.2017.4912.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................177.datagaps.........................................................................................................................................228.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................239.concerns..........................................................................................................................................239.1.issuesthatcouldnotbenalised.......................................................................................................239.2.criticalareasofconcern.....................................................................................................................239.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................24references...............................................................................................................................................25abbreviations...........................................................................................................................................27appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................29appendixbusedcompoundcodes.........................................................................................................30", "j.efsa.2017.4976.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................8conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................167.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................21abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2017.4978.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................103.1.representativeuseresidues...............................................................................................................103.2.maximumresiduelevels.....................................................................................................................124.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................167.datagaps.........................................................................................................................................177.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................177.2.datagapsidentiedforthemaximumresiduelevelapplications...........................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2017.4980.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................8conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................157.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisksidentied...........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................21abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2017.4981.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................137.datagaps.........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................169.concerns..........................................................................................................................................169.1.issuesthatcouldnotbenalised.......................................................................................................169.2.criticalareasofconcern.....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................17references...............................................................................................................................................17abbreviations...........................................................................................................................................19appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................20appendixbusedcompoundcodes.........................................................................................................21", "j.efsa.2017.4988.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references..............................................................................................................................................21abbreviations..........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................25appendixbusedcompoundcodes........................................................................................................2", "j.efsa.2017.4989.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................198.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................209.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................219.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................21references...............................................................................................................................................23abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................27appendixbusedcompoundcodes.........................................................................................................28", "j.efsa.2017.5078.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis..........................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions......................................................................................................95.ecotoxicology....................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................117.datagapsidentiedfortherepresentativeusesevaluated...................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concernsfortherepresentativeusesevaluated...................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................139.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................14abbreviations...........................................................................................................................................15appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................16appendixbusedcompoundcodes.........................................................................................................17", "j.efsa.2017.5084.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis......................................................................................................................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions......................................................................................................105.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartmentstables(14).........................................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................139.1.issuesthatcouldnotbenalised.......................................................................................................139.2.criticalareasofconcern.....................................................................................................................139.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................14references...............................................................................................................................................14abbreviations...........................................................................................................................................15appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................16appendixbusedcompoundcodes.........................................................................................................17", "j.efsa.2018.5085.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................62.environmentalfateandbehaviour....................................................................................................73.ecotoxicology..................................................................................................................................84.datagaps.......................................................................................................................................85.concerns........................................................................................................................................85.1.issuesthatcouldnotbenalised.....................................................................................................85.2.criticalareasofconcern...................................................................................................................9references...............................................................................................................................................9abbreviations...........................................................................................................................................10appendixalistofendpointsfortheactivesubstanceinthecontextofthetargetedhazardassessmentofthepotentialpbt,vpvbandpopproperties................................................................................................11", "j.efsa.2018.5126.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................187.datagaps.........................................................................................................................................248.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................269.concerns..........................................................................................................................................279.1.issuesthatcouldnotbenalised.......................................................................................................279.2.criticalareasofconcern.....................................................................................................................279.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................28references..............................................................................................................................................31abbreviations..........................................................................................................................................32appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation........................34appendixbusedcompoundcodes........................................................................................................35", "j.efsa.2018.5130.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................5theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................157.datagaps.........................................................................................................................................167.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................178.1.particularconditionsproposedfortherepresentativeusesevaluated.....................................................179.concerns..........................................................................................................................................179.1.issuesthatcouldnotbenalised.......................................................................................................179.2.criticalareasofconcern.....................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................18references..............................................................................................................................................19abbreviations..........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation........................22appendixbusedcompoundcodes........................................................................................................23", "j.efsa.2018.5133.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................8conclusionsoftheevaluation...................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................187.datagaps.........................................................................................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................239.concerns..........................................................................................................................................239.1.issuesthatcouldnotbenalised.......................................................................................................239.2.criticalareasofconcern.....................................................................................................................249.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................24references..............................................................................................................................................25abbreviations..........................................................................................................................................27appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................29appendixbusedcompoundcodes........................................................................................................30", "j.efsa.2018.5140.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................8conclusionsoftheevaluation...................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................177.datagaps.........................................................................................................................................198.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................209.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................219.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered23......................................21references..............................................................................................................................................22abbreviations..........................................................................................................................................24appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................26appendixbusedcompoundcodes........................................................................................................2", "j.efsa.2018.5146.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................103.1.representativeuseresidues...............................................................................................................113.2.maximumresiduelevels.....................................................................................................................114.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables1-4)..............................................................167.datagaps.........................................................................................................................................187.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................188.particularconditionsproposedtobetakenintoaccounttomanage......................................................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references..............................................................................................................................................21abbreviations..........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................24appendixbusedcompoundcodes........................................................................................................25", "j.efsa.2018.5150.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................21abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5151.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................6theactivesubstanceandtheformulatedproduct......................................................................................7conclusionsoftheevaluation...................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..........................................20references..............................................................................................................................................20abbreviations..........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................24appendixbusedcompoundcodes..................................................................................................", "j.efsa.2018.5152.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstancesandtheformulatedproducts....................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................124.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................177.datagaps.........................................................................................................................................187.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................208.1.particularconditionsproposedfortherepresentativeusesevaluated.....................................................209.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................21references...............................................................................................................................................21abbreviations...........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................2", "j.efsa.2018.5159.pdf": "tableofcontentsabstract..................................................................................................................................................1summary................................................................................................................................................3background............................................................................................................................................5theactivesubstanceandtheformulatedproduct......................................................................................6conclusionsoftheevaluation...................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................74.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................85.ecotoxicology....................................................................................................................................86.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................97.datagaps.........................................................................................................................................108.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................109.concerns..........................................................................................................................................109.1.issuesthatcouldnotbenalised.......................................................................................................109.2.criticalareasofconcern.....................................................................................................................109.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................10references..............................................................................................................................................11abbreviations..........................................................................................................................................11appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................13appendixbusedcompoundcodes........................................................................................................14", "j.efsa.2018.5211.pdf": "ableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................113.1.representativeuseresidues...............................................................................................................123.2.maximumresiduelevels.....................................................................................................................134environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................166.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................197.datagaps.........................................................................................................................................267.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................268.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................288.1.particularconditionsproposedfortherepresentativeusesevaluated.....................................................289.concerns..........................................................................................................................................289.1.issuesthatcouldnotbenalised.......................................................................................................289.2.criticalareasofconcern.....................................................................................................................299.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................29references...............................................................................................................................................32abbreviations...........................................................................................................................................33appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................35appendixbusedcompoundcodes..................................................................................................", "j.efsa.2018.5229.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................103.1.representativeuseresidues...............................................................................................................103.2.maximumresiduelevelsandconrmatorydatamrlreview..................................................................124.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................157.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................199.4.issuesrelatedtothemaximumresiduelevelapplications.....................................................................20references...............................................................................................................................................20abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................23appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5230.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis.....................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................127.datagaps.........................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................139.1.issuesthatcouldnotbenalised.......................................................................................................139.2.criticalareasofconcern.....................................................................................................................149.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................14references...............................................................................................................................................15abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................17appendixbusedcompoundcodes.........................................................................................................18", "j.efsa.2018.5234.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................177.datagaps.........................................................................................................................................218.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................229.concerns..........................................................................................................................................229.1.issuesthatcouldnotbenalised.......................................................................................................229.2.criticalareasofconcern.....................................................................................................................239.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................23references...............................................................................................................................................24abbreviations...........................................................................................................................................26appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation...........................27appendixbusedcompoundcode(s).......................................................................................................28", "j.efsa.2018.5251.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................8conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................147.datagaps.........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................179.concerns..........................................................................................................................................179.1.issuesthatcouldnotbenalised.......................................................................................................179.2.criticalareasofconcern.....................................................................................................................179.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................18references...............................................................................................................................................18abbreviations...........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................21appendixbusedcompoundcodes.........................................................................................................22", "j.efsa.2018.5252.pdf": "tableofcontentsabstract................................................................................................................................................1summary..............................................................................................................................................3background..........................................................................................................................................6theactivesubstanceandtheformulatedproduct....................................................................................7conclusionsoftheevaluation.................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis..........................................82.mammaliantoxicity.......................................................................................................................83.residues......................................................................................................................................103.1.representativeuseresidues..........................................................................................................123.2.maximumresiduelevels................................................................................................................134.environmentalfateandbehaviour.................................................................................................135.ecotoxicology...............................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).......................................................177.datagaps....................................................................................................................................197.1.datagapsidentiedfortherepresentativeusesevaluated..............................................................197.2.datagapsidentiedforthemaximumresiduelevelapplications......................................................218.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied...................219.concerns.....................................................................................................................................219.1.issuesthatcouldnotbenalised..................................................................................................219.2.criticalareasofconcern................................................................................................................229.2.1.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered......................................24references............................................................................................................................................26abbreviations........................................................................................................................................26appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation......................28appendixbusedcompoundcodes......................................................................................................29", "j.efsa.2018.5258.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemicalpropertiesandmethodsofanalysis.............................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................105.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables1-4)..........................................................................137.datagaps.........................................................................................................................................157.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................169.concerns..........................................................................................................................................169.1.issuesthatcouldnotbenalised.......................................................................................................169.2.criticalareasofconcern.....................................................................................................................179.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................17references...............................................................................................................................................18abbreviations...........................................................................................................................................19appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................21appendixbusedcompoundcodes.........................................................................................................22", "j.efsa.2018.5261.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................95.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................139.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................14abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................15appendixbusedcompoundcodes........................................................................................................16", "j.efsa.2018.5288.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................72.mammaliantoxicity.........................................................................................................................83.residues........................................................................................................................................113.1.representativeuseresidues............................................................................................................113.2.maximumresiduelevels..................................................................................................................124.environmentalfateandbehaviour...................................................................................................125.ecotoxicology.................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)..........................................................157.datagaps......................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................189.concerns.......................................................................................................................................189.1.concernsfortherepresentativeusesevaluated................................................................................189.1.1.issuesthatcouldnotbenalised....................................................................................................189.1.2.criticalareasofconcern..................................................................................................................199.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................19references...............................................................................................................................................21abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2018.5290.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................167.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................21abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5307.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5308.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................95.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................127.datagaps.........................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................139.1.issuesthatcouldnotbenalised.......................................................................................................139.2.criticalareasofconcern.....................................................................................................................149.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................14references...............................................................................................................................................15abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................18appendixbusedcompoundcodes.........................................................................................................19", "j.efsa.2018.5378.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................137.datagaps.........................................................................................................................................157.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................159.concerns..........................................................................................................................................159.1.issuesthatcouldnotbenalised.......................................................................................................159.2.criticalareasofconcern.....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................16references...............................................................................................................................................17abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................19appendixbusedcompoundcodes.........................................................................................................20", "j.efsa.2018.5379.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................157.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................179.concerns..........................................................................................................................................179.1.issuesthatcouldnotbenalised.......................................................................................................179.2.criticalareasofconcern.....................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................18references...............................................................................................................................................19abbreviations...........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................22appendixbusedcompoundcodes.........................................................................................................23", "j.efsa.2018.5389.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................147.datagaps.........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................169.concerns..........................................................................................................................................169.1.issuesthatcouldnotbenalised.......................................................................................................169.2.criticalareasofconcern.....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................16references...............................................................................................................................................17abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................20appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5390.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................95.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................127.datagaps.........................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................149.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................14references...............................................................................................................................................15abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18appendixbusedcompoundcodes.........................................................................................................19", "j.efsa.2018.5400.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................75.ecotoxicology....................................................................................................................................86.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................97.datagaps.........................................................................................................................................107.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................108.particularconditionsproposedtobetakenintoaccounttomanagetheriskidentied............................109.concerns..........................................................................................................................................109.1.issuesthatcouldnotbenalised.......................................................................................................109.2.criticalareasofconcern.....................................................................................................................109.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................11references...............................................................................................................................................11abbreviations...........................................................................................................................................12appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................13appendixbusedcompoundcodes.........................................................................................................14", "j.efsa.2018.5402.pdf": "tableofcontentsabstract.....................................................................................................................................................1summary...................................................................................................................................................3background...............................................................................................................................................6theactivesubstanceandtheformulatedproduct.........................................................................................7conclusionsoftheevaluation......................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.................................................72.mammaliantoxicity..............................................................................................................................83.residues.............................................................................................................................................103.1.representativeuseresidues.................................................................................................................103.2.maximumresiduelevels.......................................................................................................................124.environmentalfateandbehaviour........................................................................................................125.ecotoxicology......................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)..........................................................................167.datagaps...........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied..........................199.concerns............................................................................................................................................199.1.issuesthatcouldnotbenalised.........................................................................................................199.2.criticalareasofconcern.......................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.............................................20references.................................................................................................................................................21abbreviations.............................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation............................24appendixbusedcompoundcodes...........................................................................................................2", "j.efsa.2018.5403.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................72.mammaliantoxicity.........................................................................................................................83.residues........................................................................................................................................113.1.representativeuseresidues............................................................................................................113.2.maximumresiduelevels..................................................................................................................134.environmentalfateandbehaviour...................................................................................................145.ecotoxicology.................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)..........................................................187.datagaps......................................................................................................................................207.1.datagapsidentiedfortherepresentativeusesevaluated................................................................207.2.datagapsidentiedforthemaximumresiduelevelapplications........................................................218.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................218.1.particularconditionsproposedfortherepresentativeusesevaluated..................................................218.2.particularconditionsproposedforthemaximumresiduelevelapplications.........................................219.concerns.......................................................................................................................................229.1.concernsfortherepresentativeusesevaluated................................................................................229.1.1.issuesthatcouldnotbenalised....................................................................................................229.1.2.criticalareasofconcern..................................................................................................................229.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................229.2.issuesrelatedtothemaximumresiduelevelapplications..................................................................249.2.1.issuesnotnalisedunderthemaximumresiduelevelapplications.....................................................249.2.2.consumerriskidentiedunderthemaximumresiduelevelapplications..............................................24references...............................................................................................................................................24abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................27appendixbusedcompoundcodes.........................................................................................................28", "j.efsa.2018.5405.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................187.datagaps.........................................................................................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................219.concerns..........................................................................................................................................219.1.issuesthatcouldnotbenalised.......................................................................................................219.2.criticalareasofconcern.....................................................................................................................229.3.overviewoftheconcernsideniedforeachrepresentativeuseconsidered............................................22references...............................................................................................................................................24abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................27appendixbusedcompoundcodes.........................................................................................................28", "j.efsa.2018.5407.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................85.ecotoxicology....................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................107.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................12references...............................................................................................................................................13abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2018.5418.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................8conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................187.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................209.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................21references...............................................................................................................................................21abbreviations...........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................25appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5429.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2018.5454.pdf": "bleofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................72.mammaliantoxicity..........................................................................................................................83.residues.........................................................................................................................................104.environmentalfateandbehaviour....................................................................................................125.ecotoxicology..................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................177.datagaps.......................................................................................................................................207.1.datagapsidentiedfortherepresentativeusesevaluated.................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................218.1.particularconditionsproposedfortherepresentativeusesevaluated...................................................219.concerns........................................................................................................................................229.1.issuesthatcouldnotbenalised.....................................................................................................229.2.criticalareasofconcern...................................................................................................................229.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................23references...............................................................................................................................................24abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................27appendixbusedcompoundcodes.........................................................................................................28", "j.efsa.2018.5464.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................177.datagaps.........................................................................................................................................218.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................239.concerns..........................................................................................................................................239.1.issuesthatcouldnotbenalised.......................................................................................................239.2.criticalareasofconcern.....................................................................................................................249.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................24references...............................................................................................................................................25abbreviations...........................................................................................................................................26appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................28appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2018.5465.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................147.datagaps.........................................................................................................................................168.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................179.concerns..........................................................................................................................................179.1.issuesthatcouldnotbenalised.......................................................................................................179.2.criticalareasofconcern.....................................................................................................................189.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2018.5467.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................167.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................21references...............................................................................................................................................21abbreviations...........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................25appendixbusedcompoundcodes.........................................................................................................26", "j.efsa.2019.5557.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartmentstables(14).........................................................................157.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references...............................................................................................................................................21abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2019.5575.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis..62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................75.ecotoxicology....................................................................................................................................86.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).........................................................................97.datagaps.........................................................................................................................................107.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................108.particularconditionsproposedtobetakenintoaccounttomanagetheriskidentied............................109.concerns..........................................................................................................................................109.1.issuesthatcouldnotbenalised.......................................................................................................109.2.criticalareasofconcern.....................................................................................................................109.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)............................11references...............................................................................................................................................11abbreviations...........................................................................................................................................12appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................13", "j.efsa.2019.5595.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................93.residues...........................................................................................................................................113.1.representativeuseresidues...............................................................................................................113.2.maximumresiduelevelsandconrmatorydatamrlreview..................................................................144.environmentalfateandbehaviour......................................................................................................145.ecotoxicology....................................................................................................................................156.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)............................................................................187.datagaps.........................................................................................................................................207.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................218.1.particularconditionsproposedfortherepresentativeusesevaluated.....................................................219.concerns..........................................................................................................................................219.1.issuesthatcouldnotbenalised.......................................................................................................219.2.criticalareasofconcern.....................................................................................................................229.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................22references...............................................................................................................................................23abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................27appendixbevaluationofdataconcerningthenecessityofthiaclopridasaninsecticidetocontrolaseriousdangertoplanthealthwhichcannotbecontainedbyotheravailablemeans,includingnon-chemicalmethods28appendixcdatacollectionset...............................................................................................................29appendixdpestclassication................................................................................................................30appendixeusedcompoundcodes.........................................................................................................", "j.efsa.2019.5633.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................6datagaps................................................................................................................................................10concerns.................................................................................................................................................101.issuesthatcouldnotbenalised..........................................................................................................102.criticalareasofconcern........................................................................................................................103.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..............................................11references...............................................................................................................................................11abbreviations...........................................................................................................................................12appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation...........................13appendixbusedcompoundcodes.........................................................................................................14", "j.efsa.2019.5732.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis............................................62.mammaliantoxicity.........................................................................................................................73.residues........................................................................................................................................93.1.representativeuseresidues............................................................................................................93.2.maximumresiduelevels..................................................................................................................114.environmentalfateandbehaviour...................................................................................................115.ecotoxicology.................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)..........................................................167.datagaps......................................................................................................................................187.1.datagapsidentiedfortherepresentativeusesevaluated................................................................197.2.datagapsidentiedforthemaximumresiduelevelapplications........................................................198.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................198.1.particularconditionsproposedfortherepresentativeusesevaluated..................................................198.2.particularconditionsproposedforthemaximumresiduelevelapplications.........................................199.concerns.......................................................................................................................................199.1.concernsfortherepresentativeusesevaluated................................................................................199.1.1.issuesthatcouldnotbenalised....................................................................................................199.1.2.criticalareasofconcern..................................................................................................................209.1.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered........................................209.2.issuesrelatedtothemaximumresiduelevelapplications..................................................................21references...............................................................................................................................................21abbreviations...........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................25appendixbusedcompoundcodes.........................................................................................................26", "j.efsa.2020.5755.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables16).............................................................177.datagaps.........................................................................................................................................198.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................209.concerns..........................................................................................................................................209.1.issuesthatcouldnotbenalised.......................................................................................................209.2.criticalareasofconcern.....................................................................................................................219.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................21references...............................................................................................................................................22abbreviations...........................................................................................................................................24appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................26appendixbusedcompoundcodes.........................................................................................................27", "j.efsa.2019.5817.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................7mammaliantoxicity...................................................................................................................................8residues(consumerriskassessment)........................................................................................................8environmentalfateandbehaviour.............................................................................................................9overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments..................................................................................................13datagaps................................................................................................................................................16concerns.................................................................................................................................................161.issuesthatcouldnotbenalised..........................................................................................................162.criticalareasofconcern........................................................................................................................163.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..............................................17references...............................................................................................................................................17abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation(relevantforthecurrentassessment).................................................................................................................................19appendixbusedcompoundcodes.........................................................................................................20", "j.efsa.2019.5820.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................13abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2019.5821.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................103.1.representativeuseresidues...............................................................................................................103.2.maximumresiduelevels.....................................................................................................................114.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................136.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................157.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1issuesthatcouldnotbenalised.......................................................................................................189.2criticalareasofconcern.....................................................................................................................189.3overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................18references...............................................................................................................................................20abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2019.5842.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................104.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................167.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5).............................20references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2019.5905.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................124.environmentalfateandbehaviour......................................................................................................135.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................187.datagaps.........................................................................................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................219.concerns..........................................................................................................................................229.1.issuesthatcouldnotbenalised.......................................................................................................229.2.criticalareasofconcern.....................................................................................................................239.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................23references...............................................................................................................................................24abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................27appendixbusedcompoundcodes.........................................................................................................28", "j.efsa.2020.5985.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................8conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................82.mammaliantoxicity..........................................................................................................................93.residues.........................................................................................................................................114.environmentalfateandbehaviour....................................................................................................135.ecotoxicology..................................................................................................................................156.endocrinedisruptionpotential..........................................................................................................177.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................198.datagaps.......................................................................................................................................219.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................2210.concerns........................................................................................................................................2310.1.issuesthatcouldnotbenalised.....................................................................................................2310.2.criticalareasofconcern...................................................................................................................2310.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................24references...............................................................................................................................................24abbreviations...........................................................................................................................................26appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................28appendixbusedcompoundcodes.........................................................................................................29", "j.efsa.2020.5986.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................62.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................74.environmentalfateandbehaviour....................................................................................................85.ecotoxicology..................................................................................................................................96.endocrinedisruptionproperties........................................................................................................107.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................118.datagaps.......................................................................................................................................139.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1310.concerns........................................................................................................................................1310.1.issuesthatcouldnotbenalised.....................................................................................................1310.2.criticalareasofconcern...................................................................................................................1310.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................14references...............................................................................................................................................14abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................17appendixbusedcompoundcodes.........................................................................................................18", "j.efsa.2020.6006.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................62.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................74.environmentalfateandbehaviour....................................................................................................85.ecotoxicology..................................................................................................................................86.endocrinedisruptionproperties........................................................................................................97.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................98.datagaps.......................................................................................................................................109.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1010.concerns........................................................................................................................................1010.1.issuesthatcouldnotbenalised.....................................................................................................1010.2.criticalareasofconcern...................................................................................................................1010.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................11references...............................................................................................................................................12abbreviations...........................................................................................................................................13appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation.........................14", "j.efsa.2020.6028.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................72.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................94.environmentalfateandbehaviour....................................................................................................95.ecotoxicology..................................................................................................................................116.endocrinedisruptionproperties........................................................................................................147.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments..............................................................................158.datagaps.......................................................................................................................................159.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1710.concerns........................................................................................................................................1710.1.issuesthatcouldnotbenalised.....................................................................................................1710.2.criticalareasofconcern...................................................................................................................1810.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................18references...............................................................................................................................................22abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................24appendixbusedcompoundcodes.........................................................................................................25", "j.efsa.2020.6056.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................6datagaps................................................................................................................................................11concerns.................................................................................................................................................111.issuesthatcouldnotbenalised..........................................................................................................112.criticalareasofconcern........................................................................................................................123.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered..............................................12references...............................................................................................................................................12abbreviations...........................................................................................................................................13appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................14appendixbusedcompoundcodes.........................................................................................................15", "j.efsa.2020.6058.pdf": "ableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................81.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................82.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................187.datagaps.........................................................................................................................................208.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................219.concerns..........................................................................................................................................229.1.issuesthatcouldnotbenalised.......................................................................................................229.2.criticalareasofconcern.....................................................................................................................229.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................22references...............................................................................................................................................23abbreviations...........................................................................................................................................25appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................27appendixbusedcompoundcodes.........................................................................................................28", "j.efsa.2020.6121.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis.........................................................................................................................................62.mammaliantoxicity.........................................................................................................................73.residues........................................................................................................................................84.environmentalfateandbehaviour...................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions....................................................................................................95.ecotoxicology.................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)..........................................................117.datagaps......................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied.....................139.concerns.......................................................................................................................................139.1.issuesthatcouldnotbenalised....................................................................................................139.2.criticalareasofconcern..................................................................................................................139.2.1.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)..........................14references...............................................................................................................................................15abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................17", "j.efsa.2020.6132.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................62.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................74.environmentalfateandbehaviour....................................................................................................85.ecotoxicology..................................................................................................................................86.endocrinedisruptionproperties........................................................................................................97.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(table14).............................................................108.datagaps.......................................................................................................................................119.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1110.concerns........................................................................................................................................1110.1.concernsfortherepresentativeusesevaluated.................................................................................1110.2.issuesrelatedtothemaximumresiduelevelapplications...................................................................1110.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................11references...............................................................................................................................................12abbreviations...........................................................................................................................................13appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................15appendixbusedcompoundcodes.........................................................................................................16", "j.efsa.2020.6151.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................114.environmentalfateandbehaviour......................................................................................................125.ecotoxicology....................................................................................................................................146.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartmentstables(14)..............................................................167.datagaps.........................................................................................................................................188.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................199.concerns..........................................................................................................................................199.1.issuesthatcouldnotbenalised.......................................................................................................199.2.criticalareasofconcern.....................................................................................................................209.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................20references...............................................................................................................................................22abbreviations...........................................................................................................................................23appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................25appendixbusedcompoundcodes.........................................................................................................26", "j.efsa.2020.6156.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................127.datagaps.........................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................139.1.issuesthatcouldnotbenalised.......................................................................................................139.2.criticalareasofconcern.....................................................................................................................149.3overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................14references...............................................................................................................................................15abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................17appendixbusedcompoundcodes.........................................................................................................18", "j.efsa.2020.6181.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................95.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables1and2).......................................................117.datagaps.........................................................................................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................15references...............................................................................................................................................15abbreviations...........................................................................................................................................19appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18appendixbusedcompoundcodes.........................................................................................................1", "j.efsa.2020.6182.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................127.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................139.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................149.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5).............................15references...............................................................................................................................................20abbreviations...........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................22appendixbusedcompoundcodes.........................................................................................................23", "j.efsa.2020.6190.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................72.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................83.1.maximumresiduelevels...................................................................................................................94.environmentalfateandbehaviour....................................................................................................95.ecotoxicology..................................................................................................................................106.endocrinedisruptionproperties........................................................................................................117.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................128.datagaps.......................................................................................................................................129.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1310.concerns........................................................................................................................................1310.1.issuesthatcouldnotbenalised.....................................................................................................1310.2.criticalareasofconcern...................................................................................................................1310.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered.........................................13references...............................................................................................................................................14abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18appendixbusedcompoundcodes.........................................................................................................19", "j.efsa.2020.6227.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................72.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................94.environmentalfateandbehaviour....................................................................................................105.ecotoxicology..................................................................................................................................126.endocrinedisruptionproperties........................................................................................................157.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................168.datagaps.......................................................................................................................................189.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1910.concerns........................................................................................................................................1910.1.issuesthatcouldnotbenalised.....................................................................................................1910.2.criticalareasofconcern...................................................................................................................1910.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)...........................20references...............................................................................................................................................20abbreviations...........................................................................................................................................22appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................25appendixbusedcompoundcodes.........................................................................................................26", "j.efsa.2020.6232.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................6theactivesubstanceandtheformulatedproduct.......................................................................................7conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................157.datagaps.........................................................................................................................................178.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................189.concerns..........................................................................................................................................189.1.issuesthatcouldnotbenalised.......................................................................................................189.2.criticalareasofconcern.....................................................................................................................199.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................19references...............................................................................................................................................20abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................2", "j.efsa.2021.6237.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................72.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................94.environmentalfateandbehaviour....................................................................................................105.ecotoxicology..................................................................................................................................116.endocrinedisruptionproperties........................................................................................................147.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................158.datagaps.......................................................................................................................................169.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1710.concerns........................................................................................................................................1710.1.issuesthatcouldnotbenalised.....................................................................................................1710.2.criticalareasofconcern...................................................................................................................1710.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)..........................18references...............................................................................................................................................19abbreviations...........................................................................................................................................20appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2020.6238.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................95.ecotoxicology....................................................................................................................................96.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................117.datagaps.........................................................................................................................................127.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................13abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................16", "j.efsa.2020.6246.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis.............................................72.mammaliantoxicity..........................................................................................................................73.residues.........................................................................................................................................84.environmentalfateandbehaviour....................................................................................................95.ecotoxicology..................................................................................................................................106.endocrinedisruptionproperties........................................................................................................117.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)...........................................................138.datagaps.......................................................................................................................................159.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied......................1610.concerns........................................................................................................................................1610.1.issuesthatcouldnotbenalised.....................................................................................................1610.2.criticalareasofconcern...................................................................................................................1610.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)..........................17references...............................................................................................................................................17abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................20appendixbusedcompoundcodes.........................................................................................................21", "j.efsa.2020.6261.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theidentityofthemicro-organismandthepropertiesoftheformulatedproduct..........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicro-organism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicro-organism..............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicro-organismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................137.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................15references...............................................................................................................................................16abbreviations...........................................................................................................................................17appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................19", "j.efsa.2020.6262.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................137.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................15references...............................................................................................................................................16abbreviations...........................................................................................................................................17appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation........................19", "j.efsa.2020.6274.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................71.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................104.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................115.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................147.datagaps.........................................................................................................................................158.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................159.concerns..........................................................................................................................................169.1.issuesthatcouldnotbenalised.......................................................................................................169.2.criticalareasofconcern.....................................................................................................................169.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................16references...............................................................................................................................................20abbreviations...........................................................................................................................................21appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................23appendixbusedcompoundcodes.........................................................................................................24", "j.efsa.2020.6293.pdf": "tableofcontentsabstract...................................................................................................................................................1theactivesubstanceandtheformulatedproduct.......................................................................................3conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................115.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................137.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................15references...............................................................................................................................................16abbreviations...........................................................................................................................................17appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18", "j.efsa.2020.6294.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................104.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................115.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................137.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................159.1.issuesthatcouldnotbenalised.......................................................................................................159.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................16references...............................................................................................................................................16abbreviations...........................................................................................................................................17appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18", "j.efsa.2020.6295.pdf": "tableofcontentsabstract...................................................................................................................................................1background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartmentstables(14).............................................................127.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................159.1.issuesthatcouldnotbenalised.......................................................................................................159.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................16references...............................................................................................................................................17abbreviations...........................................................................................................................................17appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18appendixbusedcompoundcodes.........................................................................................................19", "j.efsa.2020.6296.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................71.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................72.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................94.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................95.ecotoxicology....................................................................................................................................106.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments................................................................................117.datagaps.........................................................................................................................................128.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................129.concerns..........................................................................................................................................139.1.issuesthatcouldnotbenalised.......................................................................................................139.2.criticalareasofconcern.....................................................................................................................139.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................13references...............................................................................................................................................14abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................16appendixbusedcompoundcodes.........................................................................................................17", "j.efsa.2020.6317.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................71.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................72.mammaliantoxicity............................................................................................................................83.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................104.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................115.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................127.datagaps.........................................................................................................................................137.1.datagapsidentiedfortherepresentativeusesevaluated...................................................................138.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................149.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................15references...............................................................................................................................................15abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................17", "j.efsa.2021.6381.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................94.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................105.ecotoxicology....................................................................................................................................116.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................137.datagaps.........................................................................................................................................148.particularconditionsproposedtobetakenintoaccounttomanagetherisk(s)identied........................149.concerns..........................................................................................................................................149.1.issuesthatcouldnotbenalised.......................................................................................................149.2.criticalareasofconcern.....................................................................................................................159.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered...........................................15references...............................................................................................................................................16abbreviations...........................................................................................................................................16appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................18appendixbusedcompoundcodes.........................................................................................................19", "j.efsa.2021.6385.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................61.mammaliantoxicology.......................................................................................................................62.residues...........................................................................................................................................73.ecotoxicology....................................................................................................................................94.datagaps.........................................................................................................................................95.concerns..........................................................................................................................................95.1.issuesthatcouldnotbenalised.......................................................................................................95.2.criticalareasofconcern.....................................................................................................................96.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table1).............................10references...............................................................................................................................................10abbreviations...........................................................................................................................................10appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................12appendixbusedcompoundcodes.........................................................................................................13", "j.efsa.2021.6388.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................74.environmentalfateandbehaviour......................................................................................................84.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................84.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditionsandanimpurity...............................................................................95.ecotoxicology....................................................................................................................................95.1.infectivenessandpathogenicityofpepinomosaicvirus,eustrain,mildisolateabp1andpepinomosaicvirus,ch2strain,mildisolateabp2....................................................................................................95.2.riskfromimpuritynicotine.................................................................................................................106.overviewoftheriskassessmentoftheorganismormetabolitecompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)........................117.particularconditionsproposedtobetakenintoaccountbyriskmanagers.............................................128.concernsandrelateddatagaps.........................................................................................................128.1.issuesthatcouldnotbenalised.......................................................................................................128.2.criticalareasofconcern.....................................................................................................................128.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table6)............................139.listofotheroutstandingissues..........................................................................................................13references...............................................................................................................................................14abbreviations...........................................................................................................................................14appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation...........................16appendixbusedcompoundcodes.........................................................................................................17", "j.efsa.2021.6495.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3background.............................................................................................................................................5theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................104.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................104.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentoftheorganismormetabolitecompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14)........................137.particularconditionsproposedtobetakenintoaccountbyriskmanagers.............................................147.1.particularconditionsproposedfortherepresentativeusesevaluated.....................................................148.concernsandrelateddatagaps.........................................................................................................148.1.issuesthatcouldnotbenalised.......................................................................................................148.2.criticalareasofconcern.....................................................................................................................168.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table6).............................169.listofotheroutstandingissues..........................................................................................................18references...............................................................................................................................................18abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................20", "j.efsa.2021.6496.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theidentityofthemicroorganismandthepropertiesoftheformulatedproduct...........................................6conclusionsoftheevaluation....................................................................................................................61.identityofthemicroorganism/biologicalproperties/physicalandtechnicalpropertiesandmethodsofanalysis............................................................................................................................................62.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................94.environmentalfateandbehaviour......................................................................................................104.1.fateandbehaviourintheenvironmentofthemicroorganism...............................................................114.2.fateandbehaviourintheenvironmentofanyrelevantmetaboliteformedbythemicroorganismunderrelevantenvironmentalconditions.......................................................................................................115.ecotoxicology....................................................................................................................................126.overviewoftheriskassessmentoftheorganismormetabolitecompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables1-4).........................137.particularconditionsproposedtobetakenintoaccountbyriskmanagers.............................................148.concernsandrelateddatagaps.........................................................................................................158.1.issuesthatcouldnotbenalised.......................................................................................................158.2.criticalareasofconcern.....................................................................................................................168.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table6)............................169.listofotheroutstandingissues..........................................................................................................18references...............................................................................................................................................18abbreviations...........................................................................................................................................18appendixalistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................20", "j.efsa.2021.6500.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................85.ecotoxicology....................................................................................................................................96.endocrinedisruptionproperties..........................................................................................................97.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................98.particularconditionsproposedtobetakenintoaccountbyriskmanagers.............................................109.concernsandrelateddatagaps.........................................................................................................119.1.issuesthatcouldnotbenalised.......................................................................................................119.2.criticalareasofconcern.....................................................................................................................119.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)............................1110.listofotheroutstandingissues..........................................................................................................12references...............................................................................................................................................13abbreviations...........................................................................................................................................13appendixaconsiderationofcut-offcriteriaforaccordingtoannexiiofregulation(ec)no1107/2009oftheeuropeanparliamentandofthecouncil...............................................................................................15appendixblistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................16", "j.efsa.2021.6593.pdf": "tableofcontentsabstract...................................................................................................................................................1summary.................................................................................................................................................3theactivesubstanceandtheformulatedproduct.......................................................................................6conclusionsoftheevaluation....................................................................................................................71.identity,physical/chemical/technicalpropertiesandmethodsofanalysis...............................................72.mammaliantoxicity............................................................................................................................73.residues...........................................................................................................................................84.environmentalfateandbehaviour......................................................................................................85.ecotoxicology....................................................................................................................................96.endocrinedisruptionproperties..........................................................................................................117.overviewoftheriskassessmentofcompoundslistedinresiduedenitionstriggeringassessmentofeffectsdatafortheenvironmentalcompartments(tables14).............................................................118.particularconditionsproposedtobetakenintoaccountbyriskmanagers.............................................129.concernsandrelateddatagaps.........................................................................................................129.1.issuesthatcouldnotbenalised.......................................................................................................129.2.criticalareasofconcern.....................................................................................................................129.3.overviewoftheconcernsidentiedforeachrepresentativeuseconsidered(table5)............................1310.listofotheroutstandingissues..........................................................................................................17references...............................................................................................................................................17abbreviations...........................................................................................................................................18appendixaconsiderationofcut-offcriteriaforpotassiumhydrogencarbonateaccordingtoannexiiofregulation(ec)no1107/2009oftheeuropeanparliamentandofthecouncil..............................................21appendixblistofendpointsfortheactivesubstanceandtherepresentativeformulation..........................22appendixcusedcompoundcodes.........................................................................................................23"}